Compare BEAM & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | COLM |
|---|---|---|
| Founded | 2017 | 1938 |
| Country | United States | United States |
| Employees | N/A | 9620 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2019 | 1997 |
| Metric | BEAM | COLM |
|---|---|---|
| Price | $23.29 | $60.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 8 |
| Target Price | $52.15 | ★ $69.83 |
| AVG Volume (30 Days) | ★ 1.7M | 635.9K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | $24,000.00 | ★ $3,042,478,000.00 |
| Revenue This Year | N/A | $1.78 |
| Revenue Next Year | $29.19 | $3.12 |
| P/E Ratio | ★ N/A | $51.95 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $20.23 | $47.48 |
| 52 Week High | $38.26 | $69.06 |
| Indicator | BEAM | COLM |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 60.96 |
| Support Level | $22.49 | $55.33 |
| Resistance Level | $26.72 | $65.02 |
| Average True Range (ATR) | 1.17 | 1.45 |
| MACD | 0.01 | 0.37 |
| Stochastic Oscillator | 4.89 | 73.39 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.